These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 12882798
1. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Pang IH, Hellberg PE, Fleenor DL, Jacobson N, Clark AF. Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3485-93. PubMed ID: 12882798 [Abstract] [Full Text] [Related]
2. Involvement of AP-1 in interleukin-1alpha-stimulated MMP-3 expression in human trabecular meshwork cells. Fleenor DL, Pang IH, Clark AF. Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3494-501. PubMed ID: 12882799 [Abstract] [Full Text] [Related]
3. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K, Ito A. Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436 [Abstract] [Full Text] [Related]
4. Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs. Alexander JP, Acott TS. Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2831-8. PubMed ID: 11687525 [Abstract] [Full Text] [Related]
11. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts. Lin N, Sato T, Ito A. Arthritis Rheum; 2001 Sep; 44(9):2193-200. PubMed ID: 11592385 [Abstract] [Full Text] [Related]
14. p38 MAP kinase pathway and stromelysin regulation in trabecular meshwork cells. Kelley MJ, Rose A, Song K, Lystrup B, Samples JW, Acott TS. Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3126-37. PubMed ID: 17591882 [Abstract] [Full Text] [Related]
15. Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork. Kelley MJ, Rose AY, Song K, Chen Y, Bradley JM, Rookhuizen D, Acott TS. Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2634-43. PubMed ID: 17525194 [Abstract] [Full Text] [Related]
16. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells. Sanka K, Maddala R, Epstein DL, Rao PV. Invest Ophthalmol Vis Sci; 2007 May; 48(5):2105-14. PubMed ID: 17460268 [Abstract] [Full Text] [Related]
17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints. Takei I, Takagi M, Santavirta S, Ida H, Hamasaki M, Ishii M, Fukushima S, Ogino T, Konttinen YT. J Biomed Mater Res; 1999 Jun 05; 45(3):175-83. PubMed ID: 10397973 [Abstract] [Full Text] [Related]
19. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Alexander JP, Samples JR, Acott TS. Curr Eye Res; 1998 Mar 05; 17(3):276-85. PubMed ID: 9543636 [Abstract] [Full Text] [Related]
20. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. Hofmann A, Laue S, Rost AK, Scherbaum WA, Aust G. Thyroid; 1998 Mar 05; 8(3):203-14. PubMed ID: 9545106 [Abstract] [Full Text] [Related] Page: [Next] [New Search]